HIGHLIGHTS
- who: Sruthi Ravindranathan from the The research complies with all relevant ethical regulationsStudies involving human samples were approved by the Emory Institutional Review Board (IRB). All experimental procedures involving animals were approved by the Institutional Animal Care and Use Committee (IACUC) at Emory University. have published the research: Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma, in the Journal: (JOURNAL) of 19/08/2021
- what: The authors show that inhibiting vasoactive intestinal peptide receptor (VIP-R) signaling enhances anti-tumor immunity in murine PDAC models. This study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.